Nano Labs Ltd. Sponsored ADR Class A (NA)
NASDAQ:NA
Top Page
Nano Labs Ltd. Sponsored ADR Class A
(NASDAQ:NA)
Select Model
Select Model
Rating:37Underperform
Price Target:
$3.50
▲(1.45% Upside)
Action:ReiteratedDate:12/05/25
Nano Labs Ltd. is currently facing significant financial and operational challenges, reflected in its poor financial performance and technical indicators. The company's high leverage, declining revenues, and negative profitability are major concerns. Despite some strategic shifts and cost reductions, the overall outlook remains negative, resulting in a low stock score.
Positive Factors
Large BNB Strategic Reserves
Concentrating substantial crypto reserves in BNB creates a liquid strategic asset base that management can deploy for financing, partnerships, or balance-sheet support. Over months this provides optionality to fund Web3 initiatives, stabilize liquidity or backtokenization efforts without near-term revenue dependence.
Negative Factors
Steep Revenue Decline and Gross Loss
A dramatic top-line contraction and transition to gross loss reflect structural demand or product-market fit failures for core products. Persistent revenue erosion makes fixed-cost absorption harder, undermines margins and scale economics, and raises the bar for any recovery to sustainably fund operations and R&D long term.
Read all positive and negative factors
Positive Factors
Negative Factors
Large BNB Strategic Reserves
Concentrating substantial crypto reserves in BNB creates a liquid strategic asset base that management can deploy for financing, partnerships, or balance-sheet support. Over months this provides optionality to fund Web3 initiatives, stabilize liquidity or backtokenization efforts without near-term revenue dependence.
Read all positive factors
Nano Labs Ltd. Sponsored ADR Class A (NA) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$72.37M
Dividend YieldN/A
Average Volume (3M)155.07K
Price to Earnings (P/E)3.9
Beta (1Y)0.82
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees88
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,712,923
10 Day Avg. Volume118,044
30 Day Avg. Volume155,067
Financial Highlights & Ratios
PEG Ratio0.64
Price to Book (P/B)19.06
Price to Sales (P/S)108.35
P/FCF Ratio-25.03
Enterprise Value/Market Cap23.97
Enterprise Value/Revenue71.86
Enterprise Value/Gross Profit147.28
Enterprise Value/Ebitda-31.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nano Labs Ltd. Sponsored ADR Class A Business Overview & Revenue Model
Company Description
Nano Labs Ltd operates as a fabless integrated circuit design company and product solution provider in the People's Republic of China and internationally. The company develops high throughput computing and high-performance computing chips. It also...
How the Company Makes Money
Nano Labs Ltd. generates revenue through multiple streams, primarily by selling its proprietary nanotechnology products and solutions to businesses in various sectors. These products include advanced materials for electronics, drug delivery system...
Nano Labs Ltd. Sponsored ADR Class A Financial Statement Overview
Summary
Income Statement
20
Very Negative
Balance Sheet
30
Negative
Cash Flow
25
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.14M | 40.60M | 78.34M | 983.17M | 39.44M | 2.13M |
| Gross Profit | 11.78M | 11.60M | -103.45M | 230.16M | -4.09M | 856.13K |
| EBITDA | -55.00M | -100.99M | -243.27M | 208.69M | -168.90M | -37.08M |
| Net Income | -63.01M | -113.19M | -252.82M | 31.12M | -174.94M | -37.70M |
Balance Sheet | ||||||
| Total Assets | 1.48B | 615.93M | 350.30M | 367.24M | 909.83M | 61.49M |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 275.32M | 50.53M | 91.25M | 265.74M | 35.73M |
| Total Debt | 686.79M | 198.87M | 150.88M | 23.67M | 7.35M | 5.74M |
| Total Liabilities | 858.65M | 383.03M | 366.56M | 202.83M | 934.49M | 110.01M |
| Stockholders Equity | 621.69M | 230.79M | -14.73M | 164.41M | -24.66M | -48.52M |
Cash Flow | ||||||
| Free Cash Flow | -117.39M | -175.70M | -238.96M | -341.76M | 63.04M | -3.96M |
| Operating Cash Flow | -113.36M | -139.33M | -133.47M | -274.94M | 71.73M | -3.03M |
| Investing Cash Flow | -216.44M | -256.77M | -105.48M | -33.18M | -36.05M | -1.65M |
| Financing Cash Flow | 671.67M | 375.98M | 199.52M | 161.00M | 164.90M | 29.36M |
Nano Labs Ltd. Sponsored ADR Class A Technical Analysis
Positive
3.45
Price Trends
3.04
Negative
3.34
Negative
4.63
Negative
Market Momentum
-0.03
Negative
48.93
Neutral
45.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NA, the sentiment is Positive. The current price of 3.45 is above the 20-day moving average (MA) of 2.97, above the 50-day MA of 3.04, and below the 200-day MA of 4.63, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 48.93 is Neutral, neither overbought nor oversold. The STOCH value of 45.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NA.
Nano Labs Ltd. Sponsored ADR Class A Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $79.09M | -7.47 | 8.63% | ― | 6.18% | 95.91% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $212.50M | 417.23 | -58.96% | ― | -21.59% | -254.69% | |
53 Neutral | $202.64M | -17.74 | -22.69% | ― | 22.00% | 28.06% | |
49 Neutral | $108.96M | -3.11 | -11.40% | ― | -7.79% | 10.04% | |
48 Neutral | $197.10M | -3.38 | -116.86% | ― | -94.26% | 3.20% | |
37 Underperform | $72.37M | 3.95 | -16.83% | ― | ― | ― |
* Technology Sector Average
NA
Nano Labs Ltd. Sponsored ADR Class A
3.07
-0.63
-17.03%
ASYS
Amtech Systems
14.75
11.00
293.33%
GSIT
GSI Technology
5.60
3.00
115.38%
MX
MagnaChip
2.99
0.19
6.79%
ATOM
Atomera
5.09
0.95
22.95%
ICG
Intchains Group Ltd. ADR
1.31
-0.37
-22.02%
Nano Labs Ltd. Sponsored ADR Class A Corporate Events
Nano Labs Boosts BNB Reserves Above 130,000 Tokens and Launches US$25 Million Share Buyback
Dec 31, 2025
On December 31, 2025, Nano Labs Ltd reported that it has continued to expand its strategic BNB holdings, completing a new round of acquisitions that brings its aggregate BNB position to more than 130,000 tokens, valued at about US$112 million, fur...
Nano Labs Shareholders Approve Capital Structure Changes and Class B Voting Power Increase
Dec 30, 2025
At its Annual General Meeting held on December 30, 2025 in Beijing, Nano Labs Ltd obtained shareholder approval for a series of capital structure changes and governance measures, including a conditional one-for-ten share consolidation with subsequ...
Nano Labs Ltd Announces 2025 Annual General Meeting and Key Proposals
Dec 2, 2025
On December 2, 2025, Nano Labs Ltd announced its 2025 Annual General Meeting of Shareholders to be held on December 30, 2025, in Hangzhou, China. The meeting will address several key proposals, including a share consolidation and re-designation, a...
Nano Labs Launches Strategic RWA Initiative on BNB Chain
Nov 26, 2025
On November 26, 2025, Nano Labs Ltd announced the launch of its Next Big BNB Program, a strategic initiative aimed at developing a comprehensive Real World Assets infrastructure and compliance ecosystem on the BNB Chain. This program seeks to inte...
Nano Labs Ltd Announces Early Repayment of Convertible Bonds Amid Market Volatility
Nov 12, 2025
On November 12, 2025, Nano Labs Ltd announced its decision to prepay all outstanding convertible bonds as a strategic move to enhance risk management and protect investor rights. This decision comes amid global economic uncertainty and fluctuation...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.